Australia's largest stock trading and investment forum Australia's #1 stock forum

IMM

1.64%

30.0¢ immutep limited

cytokine storm, page-42

First 42 Last

Share
Profile

Follow
tuts

5,316 Posts.

1646

26/05/20

09:10

Post #: 44831680
Share

Originally posted by snowvistaman: ↑

just providing some food for thought... sometimes you find things where you would not expect...

https://www.researchgate.net/publication/26774459_CD4CD25_regulatory_T_cells_modulate_human_dendritic_cell_chemokines_via_multiple_mechanisms

he's been at it for a while,

Frédéric Triebel founded Immutep in 2001 with John Hawken, a bioentrepreneur, to acquire the intellectual property which Triebel had created with INSERM and the Institut Gustave Roussy related to LAG3 and then move LAG3-based products into the clinic. Serono granted an exclusive worldwide license. The company raised €2.5m in venture capital in late 2003[13] and another €2.5m in January 2005.[14] Between 2001 and 2014 Immutep scientists did further basic and applied research on LAG3 and also completed a number of clinical studies, most notable in metastatic renal cell carcinoma in 2009[15] and metastatic breast cancer in 2010.[16] Immutep was sold to Prima BioMed in 2014 for US$25m.[17]

bold above by me

when you read this document.. you may just see a similar finding that is required as noted in the lancet article...

it's the name of the game. get it going or slow it down... taken to extremes... not healthy...

sometimes you find things where you would not expect....

ARTHRITIS & RHEUMATISM Vol. 60, No. 9, September 2009, pp 2848–2854© 2009, American College of Rheumatology

This line of products is useful for many conditions...

It's all about the IP...

When the products hit the market.. we will be shown the IP....

Expand

I appreciate that. I am roughly familiar with the concepts here as I work in a related field as a medical scientist and to me it doesn't appear as trivial that it sounded in your post.

IMM Price at posting: 16.0¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

What's causing the cost-of-living crisis, and how to navigate it

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins